Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
AbbVie
Pharma
Head-to-head, it's AbbVie's Rinvoq over Regeneron's Dupixent
AbbVie’s Rinvoq has shown better skin clearance than Regeneron and Sanofi’s powerhouse Dupixent in a head-to-head study in patients with eczema.
Kevin Dunleavy
Apr 26, 2024 7:39am
AbbVie's Skyrizi continues booming growth trajectory
Apr 26, 2024 12:06am
AbbVie starts open casting call for next faces of Botox ads
Apr 24, 2024 8:40am
AbbVie tops, J&J drops as physicians rank immunology players
Apr 19, 2024 7:30am
AbbVie's Rinvoq passes muster in yet another autoimmune disease
Apr 18, 2024 9:57am
Medincell, AbbVie set out to create new long-acting injectables
Apr 17, 2024 2:49pm